4d Molecular Therapeutics, Inc. · NASDAQ:FDMT

BlackRock, Inc. reported a 7.80% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 17, 2025

BlackRock, Inc. reported a 7.80% stake in 4d Molecular Therapeutics, Inc., 3,615,316 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).

Stake
7.80%
Shares
3,615,316
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.7.80%3,615,316

Source

View original at SEC

Related